House passes final opioid package 

Sep 28, 2018 - 03:01 PM
opioids

The House of Representatives today passed by a vote of 393-8 the final version of the Opioid Crisis Response Act (H.R. 6). The House-Senate agreement includes an AHA-supported provision that would allow states to receive federal Medicaid matching funds for up to 30 days per year for services provided to adults aged 21-64 for substance use disorders in Institutions for Mental Diseases. The bill also includes AHA-supported provisions addressing health insurance for former foster youth; maternal and infant health; access to telehealth and medication-assisted treatment; parity in Children’s Health Insurance Program mental health and substance use disorder benefits; a demonstration program to promote alternatives to opioids in emergency departments; revisions to the Hospital Consumer Assessment of Healthcare Providers and Systems questions relating to pain management; care coordination for drug overdose patients; and improvements to coordination of prescription drug monitoring programs. The Senate is expected to vote on the agreement in October.
 

Related News Articles

Headline
FDA approves first generic naloxone nasal spray
The Food and Drug Administration Friday approved the first generic naloxone nasal spray, an emergency treatment for opioid overdose intended for use in the…
Headline
'Take Back Day' Saturday to safely dispose of prescription drugs
April 27 is National Prescription Drug Take Back Day, an opportunity for the public to safely dispose of unwanted or expired prescription pills at sites…
Headline
NIH study to test integrated approach to prevent, treat opioid addiction
The National Institutes of Health today selected several universities to partner with communities in Kentucky, Massachusetts, New York and Ohio to study the…
Headline
Eligible hospitals can apply to participate in National Health Service Corps
Critical Access Hospitals, certain clinics, and other eligible outpatient facilities that provide primary care or substance use disorder treatment to high-need…
Headline
FDA requires opioid labeling changes to help providers safely taper dosing
The Food and Drug Administration yesterday announced changes to the prescribing information included in outpatient opioid pain medication labels.
Headline
AHRQ seeks comments on acute pain treatment resource
The Agency for Healthcare Research and Quality is accepting comments through April 25 on a draft report on treatment for acute pain.